Stand Up To Cancer - standup2cancer.orgThis is where the end of cancer begins
   Please leave this field empty

SU2C Blog

Share this:

Like this page on Facebook

A Fresh Attack on Pancreatic Cancer

Posted on November 5, 2015, 8:00 PM

We are thrilled to announce a new Transatlantic Dream Team that will unleash a fresh attack on pancreatic cancer.

This new International Dream Team created in partnership with Cancer Research UK and The Lustgarten Foundation, will be led by top researchers in both the United States and United Kingdom. Daniel D. Von Hoff, MD – physician-in chief and distinguished professor at the Translational Genomics Research Institute (TGen) in Phoenix, Arizona, chief scientific officer at HonorHealth, and professor of medicine at Mayo Clinic—will lead the team. “To eradicate pancreatic cancer will take a collaborative effort,” said Kerri Kaplan, executive director and chief operating officer of The Lustgarten Foundation. “This international collaboration will bring together leading global experts in the field of pancreatic cancer research, and together we will focus on developing new therapies and innovative approaches so patients can benefit and live longer lives.”

Each year pancreatic cancer takes the lives of approximately 40,000 people in the U.S. and 8,000 people in the U.K. It is a disease that has few early warning signs and is often diagnosed in advanced stages, leaving patients and their families with little hope and devastating outcomes. Research is the best weapon we have for creating better early detection, treatments, and a world with more pancreatic cancer survivors. With two Dream Teams already dedicated to improving the survival rates for pancreatic cancer patients, Stand Up To Cancer continues to wage an all out war on this disease.

We are already seeing results within our research, and we continue to have hope for better treatments and early detection methods. Members of one SU2C Pancreatic Dream Team showed progress when they discovered the effectiveness of a two-drug combination that led to an FDA approval. This Dream Team is now testing new three-drug combinations.

Get a closer look into SU2C’s two other Pancreatic Dream Teams:

The SU2C-The Lustgarten Foundation Pancreatic Cancer Convergence Dream Team: Transforming Pancreatic Cancer to Treatable Disease Team leaders Jaffee and Vonderheide talk about the science behind their project

Cutting off the Fuel Supply: A New Approach to the Treatment of Pancreatic Cancer Watch team leaders Von Hoff and Thompson talk about the science behind their project

Together, we are continuing to bring hope that one day all patients diagnosed with pancreatic cancer will become survivors.

Return to Blog